Viewing Study NCT00053157


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-01-21 @ 3:36 PM
Study NCT ID: NCT00053157
Status: COMPLETED
Last Update Posted: 2022-10-05
First Post: 2003-01-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Graft Versus Host Disease View
None Leukemia View
None Lymphoma View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None graft versus host disease View
None accelerated phase chronic myelogenous leukemia View
None chronic phase chronic myelogenous leukemia View
None primary myelofibrosis View
None childhood acute myeloid leukemia/other myeloid malignancies View
None childhood acute promyelocytic leukemia (M3) View
None recurrent childhood acute lymphoblastic leukemia View
None recurrent childhood acute myeloid leukemia View
None recurrent childhood large cell lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None recurrent childhood small noncleaved cell lymphoma View
None recurrent/refractory childhood Hodgkin lymphoma View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None meningeal chronic myelogenous leukemia View
None noncontiguous stage II adult diffuse large cell lymphoma View
None noncontiguous stage II adult diffuse mixed cell lymphoma View
None noncontiguous stage II adult diffuse small cleaved cell lymphoma View
None noncontiguous stage II adult Burkitt lymphoma View
None noncontiguous stage II adult immunoblastic large cell lymphoma View
None noncontiguous stage II adult lymphoblastic lymphoma View
None noncontiguous stage II grade 1 follicular lymphoma View
None noncontiguous stage II grade 2 follicular lymphoma View
None noncontiguous stage II grade 3 follicular lymphoma View
None noncontiguous stage II mantle cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult acute lymphoblastic leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult Hodgkin lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None relapsing chronic myelogenous leukemia View
None secondary acute myeloid leukemia View
None refractory chronic lymphocytic leukemia View
None stage III adult diffuse large cell lymphoma View
None stage III adult diffuse mixed cell lymphoma View
None stage III adult diffuse small cleaved cell lymphoma View
None stage III adult Burkitt lymphoma View
None stage III adult immunoblastic large cell lymphoma View
None stage III adult lymphoblastic lymphoma View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage III mantle cell lymphoma View
None stage III chronic lymphocytic leukemia View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult Burkitt lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV mantle cell lymphoma View
None stage IV chronic lymphocytic leukemia View
None untreated adult acute lymphoblastic leukemia View
None untreated adult acute myeloid leukemia View
None untreated childhood acute lymphoblastic leukemia View
None untreated childhood acute myeloid leukemia and other myeloid malignancies View
None childhood chronic myelogenous leukemia View
None chronic eosinophilic leukemia View
None chronic neutrophilic leukemia View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None noncontiguous stage II small lymphocytic lymphoma View
None noncontiguous stage II marginal zone lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage III small lymphocytic lymphoma View
None stage III marginal zone lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None childhood myelodysplastic syndromes View